NCT05230342
Personalized Nutrition Based on the Glycemic Response: Effect of Diet and Intestinal Microbiota
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 23 words
- Primary endpoints: details revised at 1 of 2 entries
- Study completion pushed from Aug 30, 2025 to Dec 31, 2026
- Publications: details revised at 12 of 12 entries
- Minor Primary completion date: Dec 31, 2024 to May 31, 2025
- Study completion date: May 30, 2025 to Aug 30, 2025
- Notable Primary completion date: Jun 2, 2024 to Dec 31, 2024v4
- Notable Primary completion date: Jun 2, 2023 to Jun 2, 2024
- Trial status: Recruiting to Active, Not Recruiting
- Study completion date: May 30, 2024 to May 30, 2025
- Site details revised at 2 of 2 sites
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of May 2, 2022 to Aug 2, 2022
- Study sites: 1 to 2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Area under the curve of postprandial glucose response
Timeframe: 2 weeks
Evaluation of the total daily interstitial glucose over 140 mg/dl
Timeframe: 2 weeks
Secondary (1)
16s ribosomal gene analysis
Arms and interventions
Nutritional strategy based on functional foodsExperimental
Participants will be provided with a nutritional strategy based on functional foods to use over the 2 week trial. These will be nopal, chía seeds, inulin, soy protein and genistein.
Placebo Ingredient GroupPlacebo comparator
The placebo group will receive a comparable set of food items that contain an equivalent number of calories per portion but without the added functional ingredients
Dietary supplements: A package containing a mix of functional foods
Other: Placebo ingredient group
Sites
2 sites in 1 country